Cabometyx

Product manufactured by Exelixis, Inc.

Application Nr Approved Date Route Status External Links
NDA208692 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Cabometyx Is A Kinase Inhibitor Indicated For The Treatment Of Patients With Advanced Renal Cell Carcinoma (Rcc) ( 1.1 ) Patients With Hepatocellular Carcinoma (Hcc) Who Have Been Previously Treated With Sorafenib ( 1.2 ) 1.1 Renal Cell Carcinoma Cabometyx Is Indicated For The Treatment Of Patients With Advanced Renal Cell Carcinoma (Rcc). 1.2 Hepatocellular Carcinoma Cabometyx Is Indicated For The Treatment Of Patients With Hepatocellular Carcinoma (Hcc) Who Have Been Previously Treated With Sorafenib.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Cabozantinib S-Malate CABOZANTINIB S-MALATE ZINC70466416

Comments